Publication: 3428

Short Communication: Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on CALGB 30610 (Alliance) / RTOG 0538
      QxMD      Google Scholar   
Citation:
Lung Cancer vol 156 68-71
Year:
2021
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
10
Parents:
3127  
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, UG1CA233253, UG1CA233324, UG1CA233327, UG1CA233329, U10CA180868 (RTOG/NRG)  
Corr. Author:
 
Authors:
                       
Networks:
CHRISTIANA, CO015, LAPS-IL057, LAPS-NC010, LAPS-TX035, NY141, SCOR   
Study
CALGB-30610
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
small cell, radiotherapy dose, fractionation